PTC Therapeutics, Inc. Amortization of Debt Issuance Costs
PTC Therapeutics, Inc. (PTCT) reported Amortization of Debt Issuance Costs of $689.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-07-30
- PTC Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $384.00K, a 27.15% increase year-over-year.
- PTC Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $305.00K, a 2.01% increase year-over-year.
- PTC Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $313.00K, a 1.95% increase year-over-year.
- PTC Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $305.00K, a 1.67% increase year-over-year.
- PTC Therapeutics, Inc. amortization of debt issuance costs for fiscal 2025 was $1.22M, a 1.75% increase from fiscal 2024.
- PTC Therapeutics, Inc. amortization of debt issuance costs for fiscal 2024 was $1.20M, a 36.04% decline from fiscal 2023.
- PTC Therapeutics, Inc. amortization of debt issuance costs for fiscal 2023 was $1.87M, a 1.47% decline from fiscal 2022.
- PTC Therapeutics, Inc. amortization of debt issuance costs for fiscal 2022 was $1.90M, a 2.87% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $689.00K 10-Q · filed 2026-07-30 | $1.00M derived: sum of 3 quarters · filed 2026-07-30 | $1.31M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $305.00K 10-Q · filed 2026-05-07 | $618.00K derived: sum of 2 quarters · filed 2026-05-07 | $923.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.23M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $618.00K derived: sum of 2 quarters · filed 2026-02-19 | $920.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.22M 10-K · filed 2026-02-19 |
| 2025-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $607.00K derived: sum of 2 quarters · filed 2026-07-30 | $906.00K 10-Q · filed 2025-11-04 | $1.21M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $601.00K 10-Q · filed 2026-07-30 | $908.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.21M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $299.00K 10-Q · filed 2026-05-07 | $606.00K derived: sum of 2 quarters · filed 2026-05-07 | $906.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $607.00K derived: sum of 2 quarters · filed 2026-02-19 | $902.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.20M 10-K · filed 2026-02-19 |
| 2024-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $595.00K derived: sum of 2 quarters · filed 2025-11-04 | $891.00K 10-Q · filed 2025-11-04 | $1.19M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $591.00K 10-Q · filed 2025-08-07 | $890.00K derived: sum of 3 quarters · filed 2026-02-19 | $1.46M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $296.00K 10-Q · filed 2025-05-06 | $595.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.17M derived: sum of 3 quarters · filed 2026-02-19 | $1.73M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $872.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.44M derived: sum of 3 quarters · filed 2026-02-19 | $1.87M 10-K · filed 2026-02-19 |
| 2023-09-30 | $573.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.14M derived: sum of 2 quarters · filed 2024-11-07 | $1.57M 10-Q · filed 2024-11-07 | $2.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.00M 10-Q · filed 2024-08-08 | $1.59M derived: sum of 3 quarters · filed 2025-02-27 | $1.97M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $438.00K 10-Q · filed 2024-04-25 | $1.02M derived: sum of 2 quarters · filed 2025-02-27 | $1.40M derived: sum of 3 quarters · filed 2025-02-27 | $1.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $966.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.44M derived: sum of 3 quarters · filed 2025-02-27 | $1.90M 10-K · filed 2025-02-27 |
| 2022-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $852.00K derived: sum of 2 quarters · filed 2023-10-26 | $1.32M 10-Q · filed 2023-10-26 | $1.79M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $935.00K 10-Q · filed 2023-08-03 | $1.41M derived: sum of 3 quarters · filed 2024-02-29 | $1.87M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $464.00K 10-Q · filed 2023-04-27 | $935.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.40M derived: sum of 3 quarters · filed 2024-02-29 | $1.86M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $937.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.40M derived: sum of 3 quarters · filed 2024-02-29 | $1.85M 10-K · filed 2024-02-29 |
| 2021-09-30 | $466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $925.00K derived: sum of 2 quarters · filed 2022-10-27 | $1.38M 10-Q · filed 2022-10-27 | $1.63M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $459.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $911.00K 10-Q · filed 2022-08-04 | $1.17M derived: sum of 3 quarters · filed 2023-02-21 | $1.42M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $452.00K 10-Q · filed 2022-05-03 | $706.00K derived: sum of 2 quarters · filed 2023-02-21 | $962.00K derived: sum of 3 quarters · filed 2023-02-21 | $1.22M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $510.00K derived: sum of 2 quarters · filed 2023-02-21 | $764.00K derived: sum of 3 quarters · filed 2023-02-21 | $1.02M 10-K · filed 2023-02-21 |
| 2020-09-30 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $510.00K derived: sum of 2 quarters · filed 2021-10-28 | $766.00K 10-Q · filed 2021-10-28 | $1.03M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $510.00K 10-Q · filed 2021-07-29 | $770.00K derived: sum of 3 quarters · filed 2022-02-22 | $924.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $256.00K 10-Q · filed 2021-05-04 | $516.00K derived: sum of 2 quarters · filed 2022-02-22 | $670.00K derived: sum of 3 quarters · filed 2022-02-22 | $811.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $414.00K derived: sum of 2 quarters · filed 2022-02-22 | $555.00K derived: sum of 3 quarters · filed 2022-02-22 | $694.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $295.00K derived: sum of 2 quarters · filed 2020-10-29 | $434.00K 10-Q · filed 2020-10-29 | $568.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $280.00K 10-Q · filed 2020-08-05 | $414.00K derived: sum of 3 quarters · filed 2021-02-25 | $548.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $139.00K 10-Q · filed 2020-04-30 | $273.00K derived: sum of 2 quarters · filed 2021-02-25 | $407.00K derived: sum of 3 quarters · filed 2021-02-25 | $537.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $268.00K derived: sum of 2 quarters · filed 2021-02-25 | $398.00K derived: sum of 3 quarters · filed 2021-02-25 | $524.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $264.00K derived: sum of 2 quarters · filed 2019-10-30 | $390.00K 10-Q · filed 2019-10-30 | $515.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $256.00K 10-Q · filed 2019-08-06 | $381.00K derived: sum of 3 quarters · filed 2020-03-02 | $504.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $126.00K 10-Q · filed 2019-05-02 | $251.00K derived: sum of 2 quarters · filed 2020-03-02 | $374.00K derived: sum of 3 quarters · filed 2020-03-02 | $479.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $248.00K derived: sum of 2 quarters · filed 2020-03-02 | $353.00K derived: sum of 3 quarters · filed 2020-03-02 | $433.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $228.00K derived: sum of 2 quarters · filed 2018-11-05 | $308.00K 10-Q · filed 2018-11-05 | $386.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $185.00K 10-Q · filed 2018-08-07 | $263.00K derived: sum of 3 quarters · filed 2019-03-01 | $340.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $80.00K 10-Q · filed 2018-05-09 | $158.00K derived: sum of 2 quarters · filed 2019-03-01 | $235.00K derived: sum of 3 quarters · filed 2019-03-01 | $310.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $155.00K derived: sum of 2 quarters · filed 2019-03-01 | $230.00K derived: sum of 3 quarters · filed 2019-03-01 | $302.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $152.00K derived: sum of 2 quarters · filed 2017-11-02 | $224.00K 10-Q · filed 2017-11-02 | $294.00K derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $147.00K 10-Q · filed 2017-08-09 | $217.00K derived: sum of 3 quarters · filed 2018-03-06 | |
| 2016-03-31 | $72.00K 10-Q · filed 2017-05-08 | $142.00K derived: sum of 2 quarters · filed 2018-03-06 | ||
| 2015-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $107.00K 10-K · filed 2018-03-06 | ||
| 2015-09-30 | $37.00K 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |